This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
ME/CFS Science
mecfsscience.org
did:plc:ith7dzcppw7ru2enoauywkld
6) The main result is shown in the figure below. Temelimab had no effect on fatigue, and the same null results were seen for the secondary outcomes, including several cognitive tests and biomarkers.
2026-07-14T07:52:42.363Z